Novartis AG

NVSEF | OTC

Price Alert Chart Builder DCF Calculator

$138.25

+$4.55 (+3.40%)

Sep 21, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020	FY 2019 Dec 30, 2019
Net Income	11.94B	9.15B	6.96B	24.02B	8.07B	7.15B
Depreciation & Amortization	6.07B	8.28B	7.18B	6.11B	6.46B	5.83B
Stock-Based Compensation	1.04B	865M	791M	700M	738M	758M
Other Working Capital	555M	1.2B	464M	570M	439M	1.01B
Other Non-Cash Items	-2.43B	-4.01B	-1.14B	-18.16B	-3.14B	-2.1B
Deferred Income Tax	1.7B	551M	1.42B	2.12B	1.81B	1.79B
Change in Working Capital	-706M	-369M	-1B	241M	-291M	199M
Operating Cash Flow	17.62B	14.46B	14.24B	15.07B	13.65B	13.63B
Capital Expenditures	-3.81B	-2.75B	-2.67B	-2.97B	-2.59B	-2.26B
Cash Acquisitions	-3.92B	-3.54B	-903M	20.1B	-9.96B	-3.77B
Purchase of Investments	-3.55B	-747M	-34.82B	-16.59B	-2.13B	-530M
Sales Maturities Of Investments	3.7B	11.6B	39.49B	2.74B	1.22B	3.71B
Other Investing Acitivies	-2.38B	1.23B	368M	931M	282M	614M
Investing Cash Flow	-7.51B	5.6B	1.47B	4.21B	-13.18B	-2.23B
Debt Repayment	4.39B	-1.79B	-2.4B	-2.44B	7.07B	-3.38B
Common Stock Repurchased	-8.33B	-8.72B	-10.65B	-3.06B	-2.84B	-5.53B
Dividend Paid	-7.62B	-7.26B	-7.75B	-7.38B	-7.42B	-6.82B
Other Financial Acitivies	-177M	3.49B	-4.79M	-3.4B	549M	1.93B
Financial Cash Flow	-11.74B	-14.28B	-20.56B	-16.26B	-2.21B	-13.63B
Net Cash Flow	-1.93B	5.88B	-4.89B	2.75B	-1.45B	-2.16B
Free Cash Flow	13.81B	11.71B	11.57B	12.1B	11.07B	11.37B
Adj. Free Cash Flow	12.76B	10.84B	10.77B	11.4B	10.33B	10.61B
Maintenance CapEx	-2.52B	-2.75B	-2.67B	-2.09B	-2.22B	-2.26B
Growth CapEx	-1.29B	n/a	n/a	-878.6M	-369.23M	n/a
Owner Earnings	15.1B	11.71B	11.57B	12.98B	11.43B	11.37B